Schlosser Mario 4
4 · Oscar Health, Inc. · Filed Jan 12, 2026
Insider Transaction Report
Form 4
Schlosser Mario
DirectorPresident of Technology & CTO
Transactions
- Conversion
Class A Common Stock
[F1][F2]2026-01-08+23,038→ 373,218 total - Sale
Class A Common Stock
[F1]2026-01-08$17.65/sh−23,038$406,621→ 350,180 total - Conversion
Class B Common Stock
[F2][F1]2026-01-08−23,038→ 1,432,293 total→ Class A Common Stock (23,038 underlying)
Holdings
- 333,333(indirect: By Trust)
Class B Common Stock
[F2][F3]→ Class A Common Stock (333,333 underlying) - 633,333(indirect: By Trust)
Class B Common Stock
[F2][F3]→ Class A Common Stock (633,333 underlying) - 333,333(indirect: By Trust)
Class B Common Stock
[F2][F3]→ Class A Common Stock (333,333 underlying)
Footnotes (3)
- [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025.
- [F2]The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.
- [F3]Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any.
Signature
/s/ Melissa Curtin, Attorney-in-fact|2026-01-12